Skip to main content
Mainz Biomed N.V. (QUCY)
NASDAQ: QUCY · Real-Time Price · USD
0.502
-0.038 (-7.04%)
At close: Apr 28, 2026, 4:00 PM EDT
0.498
-0.004 (-0.76%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Mainz Biomed Revenue

In the year 2025, Mainz Biomed had annual revenue of $537.08K, down -39.92%. Mainz Biomed had revenue of $250.36K in the half year ending December 31, 2025, a decrease of -36.85%.

Revenue (ttm)
$537.08K
Revenue Growth
-39.92%
P/S Ratio
12.58
Revenue / Employee
$20,657
Employees
26
Market Cap
6.28M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025537.08K-356.91K-39.92%
Dec 31, 2024893.99K-1.49K-0.17%
Dec 31, 2023895.48K365.60K69.00%
Dec 31, 2022529.88K-47.47K-8.22%
Dec 31, 2021577.35K83.78K16.98%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 514.03M
MDxHealth 107.88M
Biodesix 88.50M
Exagen 66.58M
XWELL 29.21M
Precipio 24.05M
bioAffinity Technologies 6.16M
iSpecimen 1.93M
Revenue Rankings

QUCY News

More News